AzTrials
AzTrials

Cardiac RehabilitationSPARCNCT07214350

Sex Differences in Barriers and Participation in Physical Activity During and Following Cardiac Rehabilitation

An observational study of Cardiac Rehabilitation and Heart Disease, run by Duke University at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The SPARC study will measure physical activity and functional fitness during cardiac rehabilitation, right after completion of cardiac rehabilitation, and 6 months later. This will help investigators learn if men and women maintain physical activity levels and functional fitness differently during and after they… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Cardiac Rehabilitation, Heart Disease
How many people
150 participants
Where
1 siteUnited States
Study dates
2 Dec 2025to Aug 2030
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adults participating in cardiac rehabilitation

Who may be able to join

  • Age > 18 years
  • Enrolled in cardiac rehabilitation within the last month
  • Own a smartphone or tablet for mobile application download

Who cannot join

  • Planned relocation during the study period out of the local area
  • Planned medical procedure within the study period that may limit physical activity (i.e., joint replacement)
  • End-stage kidney disease
  • Impairment from stroke, injury, or other medical conditions that would prevent participation in or completion of the protocol
  • Heart transplant
  • Use of a left ventricular assist device
  • Pregnant or intending to become pregnant during the study period
  • Any other illness that, in the opinion of the study physician, would negatively impact or mitigate participation in or completion of the protocol

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Katherine A Collins-Bennett, PhD contact

919-479-2368

katherine.collins-bennett@duke.edu

Johanna L. Johnson, MS contact

919-660-6766

johanna.johnson@duke.edu

United States1 site, 1 recruiting
  • Duke Center for Living

    Durham, North Carolina, 27705

    Katherine A Collins-Bennett, PhD, 919-479-2368, katherine.collins-bennett@duke.edu

    Recruiting

Other trials in United States

About this study

The SPARC study will measure physical activity and functional fitness during cardiac rehabilitation, right after completion of cardiac rehabilitation, and 6 months later. This will help investigators learn if men and women maintain physical activity levels and functional fitness differently during and after they complete cardiac rehabilitation. Participants in this study will have three in-person study visits and may complete two qualitative interviews over a 10-month study period. The greatest risks during the study include physical discomfort, falling, and/or shortness of breath during the fitness testing.

Keywords
Physical Activity, Sex Differences
Medical subject headings
Heart Diseases, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07214350
Study groupRoleWhat they receive
Adults participating in cardiac rehabilitationPhysical activity and functional fitness will be measured during cardiac rehabilitation, right after completion of cardiac rehabilitation, and 6 months later.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Average Daily Step Count

    Calculated as an average of daily steps achieved over the previous week at each timepoint.

    Measured: Baseline, 3 months, 9 months

Secondary outcomes (1)
  1. Average moderate-to-vigorous physical activity minutes per week

    Self-reported moderate-to-vigorous-intensity physical activity minutes per week using the Paffenbarger Physical Activity Questionnaire.

    Measured: 9 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Oct 2025
  2. Study start2 Dec 2025
  3. Primary completionDec 2029 (estimated)
  4. Study completionAug 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07214350
Sponsor's protocol ID
Pro00118596
Other IDs
1K01HL177266-01A1
Acronym
SPARC
Status last verified
Dec 2025
First submitted
7 Oct 2025
Last updated
3 Dec 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: This project will produce demographic, clinical and psychological obtained at baseline, 3-, and 9 months following participant enrollment. Data will be collected from a maximum of 186 research participants (total enrollment goal n = 150). To protect research participant identities, data will be de-identified; only de-identified data will be made available for sharing. Data collection will be performed at the Center for Living Campus - part of the Duke Molecular Physiology Institute - at the Duke University School of Medicine. In this proposed project for data relevant to the Specific Aims, the cleaned, item-level spreadsheet data will be shared openly, along with example transformations from initial raw data. Final files used to generate specific analyses to answer the Specific Aims and related results will also be shared. The rationale for sharing only cleaned data is to foster ease of data reuse.

Questions about this trial

What is this clinical trial studying?

An observational study of Cardiac Rehabilitation and Heart Disease, run by Duke University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 3 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Katherine A Collins-Bennett, PhD (919-479-2368, katherine.collins-bennett@duke.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Average Daily Step Count (time frame: Baseline, 3 months, 9 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Dec 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in